| 1993 |
GFI1 (Gfi-1) encodes a zinc finger protein whose overexpression in IL-2-dependent T-cell lymphoma lines promotes emergence of IL-2-independent growth, establishing its proto-oncogenic function in lymphoid cells. |
Retroviral transduction of Gfi-1/LXSN construct into IL-2-dependent T-cell lines; provirus integration mapping; Southern blot |
Molecular and cellular biology |
Medium |
8441411
|
| 1996 |
GFI1 is a 55-kDa nuclear protein that binds DNA in a sequence-specific manner to the consensus site TAAATCAC(A/T)GCA; zinc fingers 3, 4, and 5 are required for this sequence-specific DNA binding; GFI1 functions as a transcriptional repressor at target promoters. |
Random oligonucleotide selection with GST-Gfi-1 fusion protein; EMSA; DNase I footprinting; methylation interference; reporter assays with Gfi-1 binding site mutations |
Molecular and cellular biology |
High |
8754800
|
| 1996 |
The N-terminal 20-amino-acid SNAG domain of GFI1 is required for transcriptional repression activity; a P2A point mutation in the SNAG domain abolishes both transcriptional repression and the ability of GFI1 to overcome G1 arrest induced by IL-2 withdrawal, establishing the SNAG domain as the functional repressor motif. |
Transcriptional reporter assays; SNAG domain point mutagenesis (P2A); cell-cycle analysis in IL-2-starved T-cell lines |
Molecular and cellular biology |
High |
8887656
|
| 1996 |
GFI1 overexpression directly represses Bax (and Bak) transcription through GFI1 binding sites in the Bax promoter, thereby inhibiting apoptosis in IL-2-deprived T cells and primary thymocytes. |
Western blot for Bax/Bak protein; RT-PCR; Bax promoter reporter assay with Gfi-1 binding site mutations; inducible Gfi-1 transgenic thymocytes |
Proceedings of the National Academy of Sciences of the United States of America |
High |
8962093
|
| 2000 |
GFI1 physically interacts with the STAT3 inhibitor PIAS3 and can overcome PIAS3-mediated inhibition of STAT3 transcriptional activity, thereby enhancing STAT3-dependent gene expression; both proteins co-localize in nuclear dot structures. |
Yeast two-hybrid screen; co-precipitation from eukaryotic cells; co-localization immunofluorescence; transcriptional reporter assay |
The EMBO journal |
Medium |
11060035
|
| 2003 |
GFI1 is essential for neutrophil differentiation; Gfi1-null mice completely lack morphologically normal neutrophils, with myeloid progenitors arrested at a stage expressing primary but not secondary/tertiary granule proteins; re-expression of Gfi1 in sorted Gfi1−/− progenitors rescues G-CSF-induced neutrophil differentiation. |
Gene-targeted Gfi1−/− mice; BM morphology; flow cytometry; RT-PCR for granule proteins; ex vivo retroviral rescue of sorted progenitors |
Immunity |
High |
11810106 12530980
|
| 2003 |
GFI1 interacts with the co-repressor ETO (MTG8) and with HDAC1, HDAC2, and HDAC3 in vivo; a portion of GFI1/GFI1B associates with the nuclear matrix, co-localizing with ETO in punctate subnuclear structures, consistent with HDAC-dependent transcriptional repression. |
Co-immunoprecipitation from mammalian cells; nuclear matrix fractionation; co-localization immunofluorescence; in vitro binding |
Journal of cellular biochemistry |
Medium |
12874834
|
| 2003 |
GFI1 occupies the promoters of 16 target genes (including cell-cycle regulators, transcription factors, and granulocyte-specific markers) in myeloid and T-lymphocyte cell lines, as identified by large-scale chromatin immunoprecipitation, revealing direct genomic targets. |
Chromatin immunoprecipitation (ChIP) on 34 candidate gene promoters; RT-PCR expression profiling |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
12721361
|
| 2004 |
Gfi-1 restricts proliferation of hematopoietic stem cells (HSCs) and preserves their functional integrity; Gfi1-null HSCs display elevated BrdU incorporation and cell-cycle entry, and are rapidly out-competed in competitive repopulation and serial transplantation assays. |
BrdU incorporation; cell-cycle analysis; competitive repopulation assays; serial transplantation; ES cell chimeras |
Nature |
High |
15385956 15457180
|
| 2004 |
GFI1 autoregulates its own transcription by binding to conserved cis-elements in its own promoter, mediating potent transcriptional repression; GFI1B can also trans-repress the Gfi1 promoter, establishing auto- and cross-regulatory feedback. |
ChIP in primary mouse thymocytes; transcriptional reporter assays; GFI1 binding site mutagenesis; GFI1:GFP knock-in; lck-GFI1 transgene silencing of GFI1:GFP |
Nucleic acids research / The Journal of biological chemistry |
High |
15131254 15252036
|
| 2005 |
GFI1 recruits the histone lysine methyltransferase G9a and histone deacetylase 1 (HDAC1) to the p21Cip/WAF1 promoter, increasing H3K9 dimethylation and repressing p21 expression; silencing of Gfi1 in myeloid cells reverses G9a/HDAC1 recruitment and de-represses p21. |
Co-immunoprecipitation; ChIP for G9a, HDAC1, and H3K9me2 at p21 promoter; Gfi1 siRNA knockdown with RT-PCR/Western |
Molecular and cellular biology |
High |
16287849
|
| 2005 |
GFI1 functions downstream of Math1 in intestinal secretory lineage differentiation; Gfi1-null mice lack Paneth cells, have fewer goblet cells, and have supernumerary enteroendocrine cells, placing Gfi1 as a selector between goblet/Paneth versus enteroendocrine progenitor fates. |
Gfi1−/− mice; histology; gene expression profiling; genetic epistasis with Math1 |
Genes & development |
High |
16230531
|
| 2005 |
The Drosophila/mammalian transcription factors Senseless/GFI1 interact with the AXH domain of Ataxin-1; overexpression of Ataxin-1 reduces GFI1 protein levels in Purkinje cells in an AXH-domain-dependent manner, contributing to selective Purkinje cell degeneration in SCA1. |
Yeast two-hybrid; co-immunoprecipitation; Drosophila overexpression genetics; immunostaining of Gfi1 levels in Purkinje cells; AXH deletion mutant analysis |
Cell |
High |
16122429
|
| 2006 |
GFI1 physically interacts with PU.1 protein and represses PU.1-dependent transcription; this interaction blocks PU.1-induced macrophage differentiation of hematopoietic progenitors; genetic reduction of PU.1 (heterozygosity) partially rescues the mixed myeloid lineage phenotype of Gfi1−/− mice. |
Co-immunoprecipitation; transcriptional reporter assay; retroviral expression of GFI1 in primary hematopoietic progenitors; Gfi1+/− × PU.1+/− intercross with flow cytometry |
The Journal of biological chemistry |
High |
17197705
|
| 2006 |
GFI1 directly interacts with the splice factor U2AF26 and antagonizes U2AF26-promoted CD45 exon exclusion, thereby shifting alternative splicing of CD45 toward the more active CD45RB isoform and regulating T-cell receptor signaling strength. |
Co-immunoprecipitation; minigene splicing reporter assay; flow cytometry of CD45 isoforms in Gfi1-null T cells; direct GFI1-U2AF26 interaction mapping |
Nature immunology |
High |
16819553
|
| 2006 |
An intact SNAG domain is required for all Gfi1 functions in vivo; replacement of Gfi1 coding sequence with Gfi1b restores near-normal pre-T-cell and neutrophil development but fails to restore inner ear hair cell development, demonstrating domain-dependent, cell-type-specific functional equivalence. |
Gfi1 SNAG-domain knock-in mutant mice; Gfi1:Gfi1b knock-in mice; histology, flow cytometry, hearing/vestibular tests |
EMBO reports |
High |
16397623
|
| 2007 |
GFI1 and GFI1B interact with the corepressor CoREST and the histone demethylase LSD1 (and HDACs 1/2) via their SNAG repression domain; GFI1b recruits these cofactors to target gene promoters in vivo; LSD1 depletion de-represses GFI1 target genes with concomitant increase in H3K4 methylation, mediating lineage-specific hematopoietic differentiation. |
Affinity purification/mass spectrometry of Gfi-1b complexes; co-immunoprecipitation; ChIP for LSD1/CoREST at target promoters; H3K4me2/3 ChIP; LSD1/CoREST siRNA knockdown with differentiation assays |
Molecular cell |
High |
17707228
|
| 2007 |
GFI1 binds DNA sequences upstream of the CXCR4 gene and represses CXCR4 transcription in myeloid lineage cells; G-CSF promotes Gfi1 expression and concordantly down-regulates CXCR4, reducing myeloid cell responses to SDF-1 and promoting bone marrow egress. |
ChIP at CXCR4 promoter; CXCR4 reporter assay; G-CSF treatment with RT-PCR/flow cytometry in Gfi1-null vs wild-type myeloid cells; migration assay |
Blood |
Medium |
17596540
|
| 2007 |
GFI1 interacts with PRDM5 in a yeast two-hybrid screen and the two proteins co-regulate overlapping sets of hematopoiesis-associated target genes epigenetically, with PRDM5 also recruiting G9a and class I HDACs. |
Yeast two-hybrid screen; transcriptional reporter assay; ChIP for G9a/HDACs; RT-PCR expression profiling |
Molecular and cellular biology |
Medium |
17636019
|
| 2008 |
GFI1 represses IL-7Rα (Il7ra) expression in effector CD8 T cells by binding the Il7ra promoter and recruiting HDAC1, causing promoter deacetylation; this antagonizes GABPα-driven Il7ra transcription, controlling formation of IL-7Rαhigh memory-precursor versus IL-7Rαlow short-lived effector cells. |
ChIP for Gfi1 and GABPα at Il7ra promoter; histone acetylation ChIP; Gfi1-deficient CD8 T cells; viral infection model; HDAC1 co-recruitment assay |
Journal of immunology |
High |
18390712
|
| 2008 |
GFI1 stabilizes GATA3 protein in Th2 cells; in the absence of Gfi1, GATA3 undergoes enhanced ubiquitin/proteasome-dependent degradation, impairing IL-5 production and Th2 differentiation; overexpression of GATA3 rescues the Gfi1-deficient Th2 cell defect. |
Proteasome inhibitor treatment; ubiquitin immunoprecipitation; Gfi1-null Th2 cells; Western blot for GATA3; GATA3 overexpression rescue |
The Journal of biological chemistry |
High |
18701459
|
| 2009 |
GFI1 represses the Sfpi1 (PU.1) gene by displacing PU.1 from its positive autoregulatory elements; loss of Gfi1 in multipotent progenitors leads to derepression of PU.1, impairing B-cell fate choice; attenuating the PU.1/Egr module suppresses B-lineage defects in Gfi1-null MPPs, placing Gfi1 upstream of PU.1 in lymphoid commitment. |
ChIP at PU.1 autoregulatory elements; Gfi1−/− MPP flow cytometry; Sfpi1 reporter assay; genetic epistasis (Gfi1−/−/PU.1 attenuation double mutant) |
Immunity |
High |
19818654
|
| 2009 |
GFI1-LSD1 repressive complex directly binds the intergenic region of Il17a/Il17f loci and intron 1 of Cd103 in Th2 cells; TGF-β represses Gfi1 expression, releasing epigenetic repression and permitting Th17/iTreg differentiation; GFI1 represses RORγt binding to the IL-17A promoter. |
ChIP (Gfi1-LSD1 complex at Il17/Cd103 loci); histone H3K4me3 ChIP in Gfi1-null Th2 cells; T cell-specific conditional Gfi1 knockout mice; enforced Gfi1 expression; Th17/iTreg differentiation assays |
The Journal of experimental medicine |
High |
19188499
|
| 2009 |
GFI1 inhibits Th17 differentiation by blocking recruitment of RORγt to the IL-17A promoter; GFI1 expression is enhanced by IFN-γ/STAT1 and IL-4/STAT6 pathways and repressed at the promoter level by TGF-β1. |
IL-17A promoter reporter assay with RORγt ChIP; Gfi1-null T cells under Th17 conditions; retroviral overexpression; Gfi1 promoter reporter with cytokine treatment |
International immunology |
Medium |
19505891
|
| 2009 |
GFI1 represses CDKN2B (p15INK4B) without directly binding its promoter by interacting with Miz-1, which tethers GFI1 to the CDKN2B core promoter; GFI1 and c-Myc collaborate through Miz-1 to co-repress CDKN2B; Gfi1 knockdown in leukemic cells elevates p15INK4B. |
Co-immunoprecipitation of GFI1-Miz-1; ChIP at CDKN2B core promoter; CDKN2B reporter assay; siRNA knockdown in human leukemic cells; Gfi1-null mouse bone marrow cells |
Proceedings of the National Academy of Sciences of the United States of America |
High |
19164764
|
| 2009 |
Gfi1 negatively regulates Th17 differentiation by inhibiting RORγt activity; Gfi1-null T cells show enhanced IL-17 under Th17-promoting conditions; Gfi1 blocks RORγt recruitment to the IL-17A promoter (as shown by ChIP). This mechanism is distinct from Gfi1's repressive effect on iTreg differentiation. |
ChIP for RORγt at IL-17A promoter in Gfi1-overexpressing vs control cells; IL-17A promoter reporter assay; Gfi1-null T cell differentiation assays |
International immunology |
Medium |
19505891
|
| 2010 |
Gfi1 represses Id2 by binding to three conserved regions in the Id2 promoter; elevated Id2 expression in Gfi1-null hematopoietic progenitors contributes to B-cell and myeloid differentiation defects; knockdown of Id2 or Id2 heterozygosity partially rescues these defects. |
ChIP at Id2 promoter; Id2 reporter assay; Gfi1-null flow cytometry; Id2 siRNA/heterozygous genetic rescue |
Blood |
High |
20453161
|
| 2010 |
Upon LPS stimulation, GFI1 is induced in macrophages, physically interacts with NF-κB p65, and inhibits p65 binding to target gene promoter DNA, reducing TNF-α and other inflammatory cytokine expression; Gfi1-null macrophages show higher p65 promoter occupancy and elevated TNF-α after LPS. |
Co-immunoprecipitation of GFI1-p65; ChIP for p65 at TNF-α promoter in Gfi1-null vs WT macrophages; RT-PCR; LPS stimulation of primary BMDM |
Molecular and cellular biology |
High |
20547752
|
| 2010 |
GFI1 promotes RasGRP1 expression (a Ras activator) and thereby links Gfi1 transcriptional control to G-CSF signaling through the Ras/MEK/ERK pathway; Gfi1-null myeloid cells fail to activate ERK1/2 upon G-CSF stimulation but not STAT1/STAT3; RasGRP1 re-expression in Gfi1-null cells rescues ERK activation and G-CSF-induced neutrophil differentiation. |
RT-PCR/Western for RasGRP1 in Gfi1-null tissues; retroviral Gfi1 transduction; signaling assays (p-ERK, p-STAT) with G-CSF; RasGRP1 rescue retroviral expression; colony assays |
Blood |
High |
20203268
|
| 2010 |
Solution NMR structure of GFI1 zinc fingers 3–5 bound to consensus DNA reveals major-groove binding (not minor groove as previously proposed); zinc fingers 4 and 5 make base-specific hydrogen bonds between Asn382/Gln379/Asp354 and invariant adenines/cytosine in the AATC core; Asn382 mutation (N382S, found in AML) is structurally rationalized. |
Multidimensional NMR; solution structure determination of ZF3–5/DNA complex |
Journal of molecular biology |
High |
20153336
|
| 2010 |
GABP transcription factor binds and activates the Gfi1 promoter, placing GFI1 downstream of GABP in myeloid differentiation; Gabpa knockout mice show reduced Gfi1 expression and myeloid defects that are partially rescued by Gfi1 transduction. |
ChIP for GABPα at Gfi1 promoter; Gabpa conditional KO mice; Gfi1 reporter assay; Gfi1 retroviral rescue of Gabpa-null BM colony formation |
Blood |
Medium |
21705494
|
| 2010 |
Gfi1 represses CDKN1A (p21Cip1) through an indirect mechanism involving interaction with Miz-1; Gfi1 does not bind the CDKN1A promoter directly but forms a ternary complex with Miz-1 and c-Myc on the core promoter to repress p21; Gfi1 knockdown elevates p21 and reduces proliferation. |
Co-immunoprecipitation of Gfi1-Miz-1-cMyc; ChIP at CDKN1A promoter; reporter assay; Gfi1 siRNA knockdown |
Oncogene |
Medium |
20190815
|
| 2012 |
GFI1 and GFI1B are direct downstream targets of RUNX1 and are critical for endothelial-to-haematopoietic transition (EHT); in the absence of both GFI1 proteins, blood progenitors in Gfi1/Gfi1b-deficient embryos maintain endothelial gene expression and are not released from the yolk sac. |
ChIP for RUNX1 at Gfi1/Gfi1b loci; Gfi1/Gfi1b-deficient embryos; expression profiling of endothelial markers; yolk sac analyses |
Blood |
High |
22668850
|
| 2012 |
Gfi1 represses CD39 and CD73 ectonucleotidase expression by binding their promoters during Th17 differentiation; TGF-β-driven downregulation of Gfi1 is required for ectonucleotidase expression and subsequent adenosine-mediated immunosuppressive activity of Th17 cells. |
ChIP for Gfi1 at CD39/CD73 promoters; promoter reporter assays; TGF-β/IL-6 Th17 differentiation with Gfi1 manipulation; adoptive transfer tumor model |
Immunity |
Medium |
22406269
|
| 2015 |
GFI1 expression specifically marks haemogenic endothelium (HE) that generates emerging HSCs in the AGM; GFI1 proteins (GFI1 and GFI1B) recruit LSD1 to epigenetically silence the endothelial program in HE, enabling the endothelial-to-haematopoietic transition (EHT); in the absence of GFI1 proteins, HSCs and progenitors are not produced in the AGM. |
GFI1 reporter mice to mark HE; Gfi1/Gfi1b-deficient embryos; ChIP/LSD1 co-recruitment assay; AGM explant culture; flow cytometry |
Nature cell biology |
High |
26619147
|
| 2016 |
SMYD2 methylates lysine-8 within the GFI1 SNAG domain; this methylation event is required for LSD1 recruitment to GFI1 SNAG; methylation-defective GFI1 (K8 mutant) loses repressor activity, fails to recruit LSD1, shows persistence of promoter H3K4me2 marks, fails to complement GFI1 depletion phenotypes in zebrafish, and lacks pro-growth functions in lymphoid leukemia cells. |
In vitro methylation assay (SMYD2 + GFI1 SNAG peptide); co-immunoprecipitation; ChIP for LSD1 and H3K4me2; SNAG K8 mutagenesis; zebrafish knockdown complementation; leukemia cell proliferation assay |
The Biochemical journal |
High |
27480105
|
| 2007 |
The ubiquitin ligase Triad1 interacts with the DNA-binding domain of GFI1 and inhibits GFI1 ubiquitination, prolonging GFI1 protein half-life; Triad1 siRNA knockdown increases GFI1 ubiquitination; this stabilization does not require ubiquitin-ligase activity of Triad1, suggesting competition with an unidentified E3 ligase. |
Co-immunoprecipitation; ubiquitin-IP; Triad1 siRNA knockdown; GFI1 half-life assay; Triad1 domain-deletion mutant analysis; cell proliferation assay |
Blood |
Medium |
17646546
|
| 2019 |
GFI1 directly interacts with the arginine methyltransferase PRMT1 and its substrates MRE11 and 53BP1; GFI1 enables PRMT1 to bind and methylate MRE11 and 53BP1, which is necessary for their function in the DNA damage response; GFI1 deletion causes hypersensitivity to ionizing radiation in T cells. |
Co-immunoprecipitation of GFI1-PRMT1-MRE11-53BP1; methylation assay; GFI1-deficient T cells; ionizing radiation sensitivity assay; proximity ligation assay |
Nature communications |
High |
29651020
|
| 2019 |
LSD1 physically associates with GFI1 and cooperates with it to inhibit neuronal differentiation genes; GFI1 proteins that cannot recruit LSD1 are unable to drive medulloblastoma tumorigenesis; genetic ablation of LSD1 markedly impairs GFI1-driven tumor growth in vivo. |
Co-immunoprecipitation of GFI1-LSD1; GFI1 mutants defective in LSD1 recruitment; Lsd1 conditional KO in GFI1-driven MB mouse model; pharmacological LSD1 inhibitor treatment |
Nature communications |
High |
30659187
|
| 2019 |
GSK3β phosphorylates GFI1 at S94/S98, triggering its interaction with the E3 ubiquitin ligase FBXW7, leading to SCFFBXW7-mediated ubiquitination and proteasomal degradation of GFI1; a non-degradable GFI1 S94A/S98A mutant shows enhanced oncogenic activity in gastric cancer cells. |
In vitro kinase assay (GSK3β + GFI1); co-immunoprecipitation of GFI1-FBXW7; ubiquitin-IP; GFI1 S94A/S98A phospho-mutant overexpression; FBXW7-KO cell proliferation and tumorigenesis assays |
Cancer research |
High |
31289136
|
| 2022 |
In inner ear hair cells, GFI1 regulates differentiation in two distinct ways: (1) as an off-DNA transcriptional co-activator of ATOH1 by binding the same regulatory elements without directly contacting DNA, enhancing ATOH1 activity; and (2) as a DNA-binding repressor of non-hair cell (neuronal) genes. CUT&RUN identified the direct GFI1 and ATOH1 genomic targets in hair cells. |
CUT&RUN for GFI1 and ATOH1 in hair cells; motif analysis; conditional Gfi1-KO in hair cells; scRNA-seq; ATOH1/GFI1 co-expression and co-IP |
Scientific reports |
Medium |
35551236
|